Documentos relacionados

1. Clinical applications of abnormal DNA methylation in chronic myeloid leukemia.
2. Measurable residual disease in chronic myeloid leukemia.
3. Lineage-specific detection of residual disease predicts relapse in patients with chronic myeloid leukemia stopping therapy.
4. Aleukemic Chronic Myeloid Leukemia Without Neutrophilia and Thrombocytosis: A Report From the BCR::ABL1 Pathology Group.
5. Chronic Myeloid Leukemia During Pregnancy with Placental Involvement: Case Report and Literature Review.
6. Single amino acid-based PROTACs trigger degradation of the oncogenic kinase BCR-ABL in chronic myeloid leukemia (CML).
7. Análisis de la presencia de trisomía 8 en las diferentes fases de leucemia mieloide crónica.
8. Why is it critical to achieve a deep molecular response in chronic myeloid leukemia?
9. Treatment-free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors.
10. Clinical outcomes of second-generation tyrosine kinase inhibitors versus imatinib in older patients with CML.